19. The pharmaceutical company's experimental drug showed exceptional _______ in clinical trials, consistently producing significant therapeutic improvements in patients with treatment-resistant neurological disorders.
(A) bioavailability
(B) efficacy
(C) stability
(D) tolerability
答案:登入後查看
統計: A(12), B(48), C(9), D(4), E(0) #3477181
統計: A(12), B(48), C(9), D(4), E(0) #3477181